DoW Peer Reviewed Cancer, Clinical Trial Award
Grant Opportunity Analysis
The Department of the Army’s USAMRAA is seeking grant applications for the FY26 Peer Reviewed Cancer Research Program Clinical Trial Award to support clinical trials that can improve the treatment or management of cancer within the program’s topic areas. The award covers rapid implementation studies ranging from phase 0 through phase III, including trials of products, drugs or biologics, devices, clinical guidance, and emerging technologies. Applications must include a clinical trial, incorporate patient advocates, rely on supportive preclinical data with no new animal studies, and submit any required IND or IDE application by the application deadline. The program anticipates about 10 awards totaling $45 million, with awards capped at $4.5 million over four years, and the pre-application is due June 26, 2026, with full applications by invitation only due October 5, 2026.